Xiaorong Sun

810 total citations
27 papers, 605 citations indexed

About

Xiaorong Sun is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Xiaorong Sun has authored 27 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Xiaorong Sun's work include Lung Cancer Diagnosis and Treatment (9 papers), Medical Imaging Techniques and Applications (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Xiaorong Sun is often cited by papers focused on Lung Cancer Diagnosis and Treatment (9 papers), Medical Imaging Techniques and Applications (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Xiaorong Sun collaborates with scholars based in China, United States and Taiwan. Xiaorong Sun's co-authors include Ligang Xing, Jinming Yu, Jing Liu, Wen‐Wu Li, Min Dong, Dianbin Mu, Jinming Yu, Wanqi Zhu, Peng Xie and Hanxi Zhao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaorong Sun

22 papers receiving 598 citations

Peers

Xiaorong Sun

PRM

RNMI

ONCOL

Michael Yan Canada

Alberto Bonetta Italy

Xixu Zhu China

Cheng-Yen Chuang Taiwan

Ting Luo China

Krzysztof Ślosarek Poland

Feng Shi China

Fuyumi Yamamoto Japan

Xuebang Zhang China

Michael Yan Canada

Xiaorong Sun

139 ×0.4

PRM

76 ×0.2

RNMI

97 ×0.6

ONCOL

73 ×0.8

56 ×0.9

Citations per year, relative to Xiaorong Sun Xiaorong Sun (= 1×) peers Michael Yan

Countries citing papers authored by Xiaorong Sun

Since Specialization

Citations

This map shows the geographic impact of Xiaorong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Sun more than expected).

Fields of papers citing papers by Xiaorong Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Sun. The network helps show where Xiaorong Sun may publish in the future.

Co-authorship network of co-authors of Xiaorong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Sun. A scholar is included among the top collaborators of Xiaorong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Sun. Xiaorong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Dong, et al.. (2025). Resilience quantification of offshore wind farm cluster under the joint influence of typhoon and its secondary disasters. Applied Energy. 383. 125323–125323. 3 indexed citations

Sun, Yi, et al.. (2025). Radiation Exposure to Patients and Others During Therapy for Pediatric Neuroblastoma With Lu-177-DOTATATE. Clinical Nuclear Medicine. 50(6). 480–485.

Sun, Xiaorong, et al.. (2024). Effect of overexpression of GRN on the proliferation and osteogenic capacity of human periodontal cells. Experimental and Therapeutic Medicine. 29(2). 33–33.

Sun, Xiaorong, et al.. (2024). Computed tomography‐based radiomics and clinical‐genetic features for brain metastasis prediction in patients with stage III/IV epidermal growth factor receptor‐mutant non‐small‐cell lung cancer. Thoracic Cancer. 15(27). 1919–1928. 2 indexed citations

Li, Siqi, et al.. (2024). Application of modified Curie and SIOPEN skeleton scoring systems in 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma. Annals of Nuclear Medicine. 39(4). 353–363. 2 indexed citations

Qu, Jialin, et al.. (2024). The analysis of multiple omics and examination of pathological images revealed the prognostic and therapeutic significances of CD93 in lung squamous cell carcinoma. Life Sciences. 339. 122422–122422. 3 indexed citations

Sun, Xiaorong, et al.. (2024). The hybrid operation based on microsurgery assisted by intraoperative spinal angiography in patients with spinal dural arteriovenous fistula: a series of 45 cases from multicenter research. Chinese Neurosurgical Journal. 10(1). 22–22.

Qu, Jialin, et al.. (2023). Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy. BMC Cancer. 23(1). 549–549. 1 indexed citations

Li, Li, Wei Zhao, Xiaorong Sun, et al.. (2020). 18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer. Translational Lung Cancer Research. 9(4). 1324–1332. 18 indexed citations

10.

Liu, Jing, Min Dong, Xiaorong Sun, et al.. (2016). Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS ONE. 11(1). e0146195–e0146195. 147 indexed citations

11.

Huang, Yong, Song Gao, Xiaorong Sun, et al.. (2016). 18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 43(13). 2336–2342. 33 indexed citations

12.

Sun, Xiaorong, et al.. (2015). The role of 18F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor. OncoTargets and Therapy. 8. 1967–1967. 24 indexed citations

13.

Su, Yan, et al.. (2015). Abnormal increased re-released Hb from RBCs of an intrahepatic bile duct carcinoma patient was detected by electrophoresis release test. Bio-Medical Materials and Engineering. 26(1_suppl). S2049–54.

14.

Zhao, Hanxi, Peng Xie, Xiaolin Li, et al.. (2015). A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer. Radiotherapy and Oncology. 114(3). 351–356. 57 indexed citations

15.

Zhao, Hanxi, Wanqi Zhu, Peng Xie, et al.. (2014). A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. Radiotherapy and Oncology. 110(1). 132–136. 63 indexed citations

16.

Yang, Wenfeng, Yongming Zhang, Zheng Fu, et al.. (2010). Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 37(7). 1291–1299. 45 indexed citations

17.

Yu, Jinming, Ligang Xing, Dianbin Mu, et al.. (2009). Comparison of Tumor Volumes as Determined by Pathologic Examination and FDG-PET/CT Images of Non–Small-Cell Lung Cancer: A Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 75(5). 1468–1474. 53 indexed citations

18.

Yang, Wenfeng, Zheng Fu, Jinming Yu, et al.. (2008). Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Lung Cancer. 61(1). 35–43. 62 indexed citations

19.

Li, Xiao‐Feng, Yuanyuan Ma, Na Fang, et al.. (2007). Changes in the Levels of CD4 ⁺ and CD8 ⁺ T-Lymphocytes After Strontium-89 Chloride Therapy for Painful Bone Metastases in Patients Correlate with Treatment Efficacy. Cancer Biotherapy and Radiopharmaceuticals. 22(3). 367–373. 11 indexed citations

20.

Wang, Hui, Jinming Yu, Guoren Yang, et al.. (2007). Assessment of ¹¹C‐labeled‐4‐N‐(3‐bromoanilino)‐6, 7‐dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression. Cancer Science. 98(9). 1413–1416. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact